Brief: Diamyd Medical Aligns With FDA On Key Elements For An Accelerated Approval Process

Diamyd Medical AB

13/12/2024 11:23

Dec 13 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL ALIGNS WITH FDA ON KEY ELEMENTS FOR AN
ACCELERATED APPROVAL PROCESS
    * DIAMYD MEDICAL AB - DETAILS OF FDA INTERACTION EXPECTED IN
JANUARY 2025
    * DIAMYD MEDICAL AB - EARLY READOUT FOR PHASE 3 DIAGNODE-3
TRIAL
PLANNED FOR MARCH 2026

Source text:  ID:nPn95SmCRa 
Further company coverage:  DMYDb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))